Literature DB >> 21436272

Mechanism of voriconazole-induced transient visual disturbance: reversible dysfunction of retinal ON-bipolar cells in monkeys.

Junzo Kinoshita1, Noriaki Iwata, Mitsuhiro Ohba, Tomofumi Kimotsuki, Mitsuya Yasuda.   

Abstract

PURPOSE: To investigate the mechanism of voriconazole-induced transient visual disturbance in humans.
METHODS: andard full-field electroretinograms (ERGs) were recorded from monkeys treated intravenously with voriconazole. In addition, photopic ERGs elicited by long-duration stimuli (ON-OFF response) were also recorded from monkeys receiving intravenous voriconazole or intravitreal 2-amino-4-phosphonobutyric acid (APB).
RESULTS: aracteristic changes were observed in the waveform of the standard full-field ERGs obtained immediately after dosing of voriconazole as follows: electronegative combined rod-cone response (markedly attenuated b-wave and oscillatory potentials), undetectable rod response (eliminated b-wave); slightly abnormal single-flash cone response (flattened appearance in the bottom of the a-wave, mildly attenuated b-wave); and slightly abnormal 30 Hz flicker (mildly attenuated b-wave). The above changes fully recovered to baseline 24 hours after each dosing, along with a decrease in plasma voriconazole concentration. In addition, the change in the waveform of the ON-OFF response recorded in voriconazole-treated monkeys was quite similar to that recorded in APB-treated monkeys as follows: the b-wave was eliminated or prominently attenuated; and the a- and d-waves were not apparently attenuated.
CONCLUSIONS: The results strongly suggest that voriconazole induces selective and reversible dysfunction of the retinal ON-bipolar cells in both the rod and cone pathways in monkeys. From the results obtained in monkeys in this study, it is suggested that the function of the retinal ON-bipolar cells was selectively and reversibly affected in voriconazole-treated humans who complained of transient visual disturbances.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436272     DOI: 10.1167/iovs.11-7183

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Induction of retinal-dependent calcium influx in human melanocytes by UVA or UVB radiation contributes to the stimulation of melanosome transfer.

Authors:  Qing-Mei Hu; Wen-Juan Yi; Meng-Yun Su; Shan Jiang; Shi-Zheng Xu; Tie-Chi Lei
Journal:  Cell Prolif       Date:  2017-08-23       Impact factor: 6.831

2.  Voriconazole, an antifungal triazol that causes visual side effects, is an inhibitor of TRPM1 and TRPM3 channels.

Authors:  Wei-Hong Xiong; R Lane Brown; Brian Reed; Neal S Burke; Robert M Duvoisin; Catherine W Morgans
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-03       Impact factor: 4.799

3.  Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.

Authors:  Woo J Moon; Erica L Scheller; Anupam Suneja; Jacob A Livermore; Anurag N Malani; Varsha Moudgal; Lisa E Kerr; Eric Ferguson; David M Vandenberg
Journal:  Clin Infect Dis       Date:  2014-07-03       Impact factor: 9.079

Review 4.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 5.  The Rise of Coccidioides: Forces Against the Dust Devil Unleashed.

Authors:  Marley C Caballero Van Dyke; George R Thompson; John N Galgiani; Bridget M Barker
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

6.  Retinal manifestations in patients following COVID-19 infection: A consecutive case series.

Authors:  Mallika Goyal; Somasheila I Murthy; Sridhar Annum
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

7.  24(S)-Hydroxycholesterol protects the ex vivo rat retina from injury by elevated hydrostatic pressure.

Authors:  Makoto Ishikawa; Takeshi Yoshitomi; Charles F Zorumski; Yukitoshi Izumi
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.